I-BET151 suppresses osteoclast formation and inflammatory cytokines secretion by targetting BRD4 in multiple myeloma

Background: Multiple myeloma (MM) is an incurable hematologic cancer, accompanied by excessive osteoclast formation and inflammatory cytokine secretion. The mechanisms by which bromodomain and extra-terminal domain (BET) protein inhibitor I-BET151 regulates osteoclast differentiation and inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ning-Hong, Zheng, Ji-Fu, Zi, Fu-Ming, Cheng, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522735/
https://www.ncbi.nlm.nih.gov/pubmed/30455393
http://dx.doi.org/10.1042/BSR20181245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522735/
https://www.ncbi.nlm.nih.gov/pubmed/30455393
http://dx.doi.org/10.1042/BSR20181245

Ejemplares similares